APRIL 1, 2011 VOLUME 286 NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 11415

Size: px
Start display at page:

Download "APRIL 1, 2011 VOLUME 286 NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 11415"

Transcription

1 THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 286, NO. 13, pp , April 1, by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A. Intensity of Deoxycytidine Deamination of HIV-1 Proviral DNA by the Retroviral Restriction Factor APOBEC3G Is Mediated by the Noncatalytic Domain * S Received for publication, November 1, 2010, and in revised form, February 6, 2011 Published, JBC Papers in Press, February 7, 2011, DOI /jbc.M Yuqing Feng 1 and Linda Chelico 2 From the Department of Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada APOBEC3G is a single-stranded (ss) DNA deaminase that restricts replication of HIV-1 by inducing viral genome mutagenesis through deamination of cytosine to uracil on HIV-1 cdna. APOBEC3G has polydisperse oligomeric states and deaminates ssdna processively through jumping and sliding. APOBEC3G has a catalytically inactive N-terminal CD1 domain that mediates processivity and an active C-terminal CD2 domain that catalyzes deaminations. Here, we assess the determinants of APOBEC3G deamination efficiency mediated by the CD1 domain by comparing native APOBEC3G and two CD1 mutants, a monomeric mutant (F126A/W127A) and a clinical mutant associated with high viral loads (H186R). Biochemical assays on ssdna or partially dsdna and with a reconstituted HIV replication system demonstrate that both mutants of Apo3G have altered DNA scanning properties in either jumping (F126A/W127A) or sliding (H186R), which results in decreased abilities to induce mutagenesis during reverse transcription. The data reveal a functionality for Apo3G oligomers in deamination and provide the first biochemical characterization of the clinical mutant H186R. The data demonstrate that the balance between the jumping and sliding of Apo3G is needed for efficient mutational inactivation of HIV-1. APOBEC3G (Apo3G) is a single-stranded (ss) 3 DNA cytosine deaminase that is most highly expressed in blood leukocytes such as T lymphocytes and macrophages (1, 2). In these cells, Apo3G functions as a host restriction factor that can block replication of virus infectivity factor (Vif)-deficient HIV-1 virions (1, 3 5). Vif mediates the polyubiquitination and degradation of Apo3G (6 10). In the absence of Vif, Apo3G can gain access to budding HIV-1 virions through interactions with * This work was supported in part by a discovery grant from the Natural Sciences and Engineering Research Council of Canada, a new investigator establishment grant from the Saskatchewan Health Research Foundation, and tri-council recognition award from the College of Medicine at the University of Saskatchewan (to L. C.). S The on-line version of this article (available at contains supplemental Table S1 and Figs. S1 S5. 1 Supported by a University of Saskatchewan Summer Student Employment Program-Board of Governors Scholarship. 2 To whom correspondence should be addressed: Dept. of Microbiology and Immunology, University of Saskatchewan, 107 Wiggins Rd., Saskatoon, Saskatchewan S7N 5E5, Canada. Fax: ; linda.chelico@ usask.ca. 3 The abbreviations used are: ss, single-stranded; Vif, viral infectivity factor; PPT, polypurine tract; NC, nucleocapsid; nt, nucleotides; AFM, atomic force microscopy. RNA and nucleocapsid (NC) and associate with the viral ribonucleoprotein complex (11 19). In the next target cell, when reverse transcription of the HIV-1 genome to ( )-DNA begins and the RNA genome is being degraded by the reverse transcriptase (RT)-associated RNase H, Apo3G can gain access to ssdna regions and deaminate cytosine (C) to uracil, preferably in 5 CCC or 5 CC motifs (underlined C is deaminated) (20). Upon replication of the ( )-DNA to ( )-DNA, the HIV-1 RT is forced to incorporate an adenine (A) opposite the uracils thereby inducing numerous C/G3 T/A mutations. These mutations can functionally inactivate HIV-1. Because Apo3G is an ssdna deaminase, the deamination events are limited to the ( )-DNA strand (20). Apo3G deaminations are biased in two regions of the HIV-1 ( )-DNA that remain single-stranded the longest due to HIV-1 replication dynamics (20, 21). The first strand of cdna is synthesized using a host trna Lys,3 primer (22). The second strand of DNA is synthesized using two RNase H-resistant polypurine tracts (PPT) located in the middle and 3 -end of the HIV-1 genome (21, 22). These RNA/DNA hybrid regions allow ( )- strand replication to begin concurrently at two locations, which limits the time that the ( )-DNA is single-stranded and can protect HIV-1 from extensive mutagenesis induced by Apo3Gcatalyzed deaminations (21, 23). The ( )-DNA regions 3 of the PPTs remain single-stranded the longest and incur the most deaminations (20, 21). This results in two gradients of deamination that increase in the direction on the ( )-DNA and correspond to mutational gradients in the genome strand of the proviral DNA (20, 21). In vitro, Apo3G demonstrates a deamination bias on naked ssdna (24 26). The inherent catalytic bias of Apo3G may enhance the temporally induced mutational bias during HIV-1 replication (21). Apo3G deaminates with a bias even though it binds randomly to ssdna and does not use an energy source, i.e. ATP or GTP (24). Apo3G is a polydisperse enzyme and exists as multiple forms, such as monomer, dimer, and tetramer, depending on the presence or absence of salt and nucleic acid (26). Elucidation of the mechanism of directionality was confounded by the polydisperse nature of Apo3G. Recently, a monomeric mutant of Apo3G (F126A/W127A) that disrupted the major head-head dimer form but retained the directional properties of Apo3G on ssdna was characterized and demonstrated that the key properties of the deamination bias are that Apo3G has a catalytic orientational specificity in the active site and a high affinity interaction with ssdna, which may result in a conformational change of the APRIL 1, 2011 VOLUME 286 NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 11415

2 substrate (25, 26). The dimer interface, which includes Phe-126 and Trp-127 as well as Tyr-124 and Tyr-125, is located on loop 7 in the N-terminal half of Apo3G, termed the CD1 (25, 27, 28). Apo3G catalyzes deaminations processively (24 26). Processivity appears to be mediated by the CD1 (25). The CD1 domain contains a deamination motif that is catalytically inactive but can bind nucleic acids (29, 30). The CD2 domain near the C terminus contains the active deaminase domain (29, 30). As a result, the CD1 domain contributes indirectly to catalysis by mediating the ssdna scanning mechanism of Apo3G (25). Previous to these data (25), the CD1 was thought to only mediate incorporation of Apo3G into virions through RNA binding (29). The ssdna scanning mechanism of Apo3G appears to be by facilitated diffusion that entails a threedimensional search involving both sliding and hopping or jumping movements (24, 31). Compared with a one-dimensional mechanism involving only sliding movements, a three-dimensional processive mechanism has the potential to increase the searching efficiency over a large area of DNA because the enzyme can move nonlinearly and sample both closely and distantly spaced regions in succession (32 34). A consequence of this type of movement is that the deaminations catalyzed by Apo3G are stochastic (31). The stochastic properties may have a beneficial role in vivo because the mutations induced by Apo3G in HIV-1 proviral DNA will always be different, thereby avoiding selective pressure on the virus. However, the restriction mechanism of Apo3G is still not a sure fire way to inactivate HIV-1. Recently, it has been demonstrated through experimental and theoretical work that if Apo3G does not induce a sufficient mutational load in the HIV-1 genome, the genetic changes may contribute to adaptive viral evolution by sublethal mutagenesis (35 39). All together, these data have raised the issue as to whether the mutagenesis-based restriction mechanism of Apo3G can be reliably developed as a novel HIV-1 therapy (37, 40). Here, we have examined the deamination mechanisms of native Apo3G and two CD1 mutants, the monomeric mutant F126A/W127A (F/W mutant) (25) and the naturally occurring H186R mutant of Apo3G (41, 42). The H186R mutant is a polymorphism that has been associated with high viral loads and decreased CD4 T-cell counts in HIV-1-infected patients (41, 42). The H186R mutant is still catalytically active and, in cell culture, can be incorporated into budding HIV-1 virions making the mechanism for its deficiency in HIV-1-infected patients unknown (41). This is the first analysis of how a monomeric mutant of Apo3G scans ssdna and the first biochemical characterization of the clinical Apo3G mutant H186R. We characterized how these Apo3G forms deaminate ssdna, partially dsdna, and ssdna being actively synthesized in a model in vitro HIV replication system. Both the F/W mutant and H186R have altered DNA scanning properties from native Apo3G. We propose a model that accounts for the functionality of a dual sliding and jumping scanning mechanism in ensuring Apo3G causes HIV-1 gene inactivation and avoids sublethal mutagenesis. EXPERIMENTAL PROCEDURES Site-directed Mutagenesis and Cloning Primers were obtained from Integrated DNA Technologies and are listed in supplemental Table S1. The Apo3G H186R mutant was constructed by site-directed mutagenesis (QuikChange site-directed mutagenesis protocol, Stratagene) using the pacg2t- Apo3G vector as the template (24). The coding sequence for HIV-1 NC (55 amino acids) was cloned into the pacg2t vector using the EcoRI site after PCR amplification of a synthetic ssdna NC sequence. Construction of native Apo3G and the F/W mutant has been described previously (24, 25). For the model HIV replication assay, the pet-blue-1 vector was modified by site-directed mutagenesis to include a PPT sequence (5 AAA AGA AAA GGG GGG A) followed by XhoI and MfeI sites immediately downstream of the existing XbaI site. A 120-nucleotide (nt) segment of the protease gene (nt ) from the HIV-1 clone 93th253.3 (GenBank TM accession number U51189) was amplified and cloned into the XhoI and MfeI sites of the modified pet-blue-1 vector that was renamed as pet-blue-ppt-prot. The HIV-1 clone was obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health; p93th253.3 was from Dr. Feng Gao and Dr. Beatrice Hahn (43). Protein Expression and Purification Recombinant baculovirus for expression of GST-NC and GST-Apo3G proteins (native and mutant) was constructed as described previously (24, 44). Sf9 cells were infected with recombinant NC or Apo3G virus at a multiplicity of infection of 1 and harvested after 72 h. Cells were lysed and purified as described previously to obtain NC or Apo3G protein cleaved from the GST tag (25). Cleaved protein fractions were stored at 70 C. The NC and Apo3G forms are 95% pure. HIV-1 RT p66/p51 (45) was generously provided by Dr. Stuart F. J. Le Grice (NCI, National Institutes of Health). Deamination Assays DNA substrates with partial dsdna regions were formed by heat annealing. Apo3G processivity and polarity on ssdna or partially dsdna substrates was measured in reactions containing 100 or 500 nm fluoresceinlabeled ssdna and nm Apo3G in RT buffer (50 mm Tris, ph 7.5, 40 mm KCl, 10 mm MgCl 2,1mMDTT) and incubated for min at 37 C. Deaminations were detected by the uracil DNA glycosylase assay, as described previously (24). Gel band intensities were visualized with a Typhoon Trio (GE Healthcare) multipurpose scanner and then measured with ImageQuant software (GE Healthcare). Processivity and processive efficiency were calculated as described previously (24, 31). DNA oligonucleotides were a gift from Dr. Myron F. Goodman (University of Southern California), and the sequences are listed in supplemental Table S1. Steady State Rotational Anisotropy Assays Apo3G-RNA or -DNA binding were monitored by changes in steady state fluorescence depolarization (rotational anisotropy). DNA was fluorescently labeled with fluorescein-dt. DNA was labeled through chemical synthesis (supplemental Table S1). Fluorescently labeled RNA consisting of the 120-nt region of the HIV-1 protease gene was produced by transcribing the DNA sequence JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 NUMBER 13 APRIL 1, 2011

3 cloned into the psp72 vector (Promega) using EcoRI and BglII sites, with T7 RNA polymerase and a pool of nucleotides containing fluorescein-12-utp (Roche Applied Science). Reaction mixtures (80 l), containing an F-labeled RNA or DNA (50 nm) in RT buffer and varying concentrations of nm native or mutant Apo3G, were incubated at 25 C. Rotational anisotropy was measured using a QuantaMaster QM-4 fluorometer (Photon Technology International) with a single emission channel. Samples were excited with vertically polarized light at 494 nm, and both vertical and horizontal emission were monitored at 520 nm (2.5-nm band pass). Model HIV Replication Assay The pet-blue-ppt-prot vector was linearized with SmaI. A 423-nt RNA consisting of the HIV-1 PPT and segment of the protease gene fused to lacz was produced and purified after incubation of the linearized DNA with T7 RNA polymerase, rntps, and buffer according to manufacturer s instructions (Promega RiboMAX Kit). A primer-template was formed by heat-annealing a synthetic DNA primer to the 3 -end of the RNA (supplemental Table S1). The reverse transcription/replication reaction contained 50 nm primer-template, 500 M dntps, 2.4 M HIV-1 RT (p66/ p51), 3 M NC, with or without Apo3G (0.2 M) in RT buffer. The concentrations of reaction components were modeled from expected concentrations in a virion (60 nm radius) according to the literature and added relative to the genomic RNA (22, 46 48). Reactions were incubated at 37 C for 90 min. The reaction was stopped by the addition of 0.5% SDS and 2.5 mm EDTA, followed by proteinase K treatment to digest the proteins (0.5 g/ l, 30 min at 25 C). The sample was then extracted with phenol/chloroform/isoamyl alcohol and buffer exchanged with a Micro BioSpin P6 column (Bio-Rad). This cleaned reaction was subjected to a PCR using Pfu Cx (Stratagene), a polymerase that can use uracil as a template base. The PCR products were digested with XhoI and EcoRI and ligated into a pet-blue-ppt-prot vector cut with compatible ends. Cutting the vector at these restriction sites removed the original lacz region and allowed for the reaction product lacz region to be the complementing -galactosidase gene. The plasmids were transformed into Escherichia coli DH5 cells and plated on Luria-Bertani medium containing X-Gal and isopropyl 1-thio- -D-galactopyranoside. The number of white colonies, which contain mutated plasmid clones, to the total number of colonies (blue and white) was scored. Twenty five white colonies were grown for plasmid preparations and sequencing at the National Research Council DNA Sequencing Facility (Saskatoon, Saskatchewan, Canada). We have sequenced 25 plasmids recovered from blue (nonmutated) E. coli colonies and found no mutations demonstrating that the white/total colony ratio can be used as a measure of mutation frequency, in agreement with other assays using a lacz reporter sequence (44, 49, 50). Sequences were analyzed using ClustalW. Statistical significance of differences in mutation frequency and mutation spectra between reaction conditions were determined by using a paired t test. Multiangle Light Scattering Apo3G (200 g) native or H186R was subjected to size exclusion chromatography using a Superdex 200 HR10/300 column (GE Healthcare) connected to an Agilent 1200 HPLC. A solution containing 50 mm HEPES, ph 6.7, and 200 mm Na 2 SO 4 was used as the elution buffer. Chromatography was performed at 0.5 ml min 1, and the column effluent was passed directly on line into a multiangle light scattering detector (Heleos II with QELS capacity, Wyatt Corp.) and refractometer (Optilab rex, Wyatt Corp.). Data analysis to determine molecular masses was performed with ASTRA software (51). Experiments were conducted at the Keck Foundation Biotechnology Resource Laboratory at Yale University (52). Atomic Force Microscopy (AFM) Apo3G imaging buffer (25 mm Tris, ph 7.3, 5 mm MgCl 2, 0.1 mm DTT) and sample were prepared as described previously (25). All AFM images were captured in air using an Agilent 4500 AFM operating in magnetic alternating contact mode. Experiments were conducted at the Saskatchewan Structural Sciences Centre, University of Saskatchewan. Vista Probes noncontact probes (Nanoscience Instruments, Phoenix, AZ) with resonance frequencies of 170 khz were used for imaging. Images were collected at a speed of 1 2 Hz with an image size of 1 1 m at pixel resolution. Volume analysis was done as described previously (53, 54). RESULTS Apo3G is a polydisperse oligomeric protein (26). Oligomerization is important for virion incorporation of Apo3G (12, 27, 55, 56), but the utility of oligomers thereafter is unclear. Although it is accepted that Apo3G must transverse DNA/RNA hybrid regions by jumping or intersegmental transfer during HIV replication to search for ssdna regions where deaminations can occur (24, 57, 58), the structural determinants of the processive jumping and sliding mechanism are not known. Here, we address the key mechanistic features necessary for Apo3G to catalyze processive deaminations using the F/W mutant and H186R mutant of Apo3G for loss of function analysis. Processivity and Polarity of Native and Mutant Apo3G We examined if differences in the deamination mechanisms for native Apo3G and the mutants, F/W mutant and H186R, exist by using synthetic ssdna substrates with two 5 CCC deamination motifs spaced different distances apart. From these data, we can determine the degree of preference for deaminating C residues at the 5 -ssdna end and if the mutants are able to deaminate two cytosine residues processively (31). These are hallmark features for native Apo3G (24). Deamination of two 5 CCC motifs 28 nt apart was tested on a synthetic ssdna with a total length of 85 nt. The reactions were performed under single hit conditions ( 15% substrate usage), which, by Poisson statistics, ensures that any given ssdna substrate is acted on by at most one form of Apo3G (monomer or oligomer) (59). The specific activity of the native and mutant enzymes on this substrate differed, and the time course was varied for each enzyme to achieve 15% substrate usage. The specific activities were as follows: Apo3G, 8.7 pmol g 1 min 1 ; F/W mutant, 22 pmol g 1 min 1 ; and H186R mutant, 4.5 pmol g 1 min 1. Native Apo3G demonstrates a 3.5-fold preference for deamination of the C residue proximal to the 5 -ssdna end (Fig. 1A, APRIL 1, 2011 VOLUME 286 NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 11417

4 FIGURE 1. Apo3G native and mutant processivity and polarity on ssdna and partially dsdna. A, deamination of an 85-nt fluorescein (F)-labeled ssdna substrate by native and mutant Apo3G. Two 5 CCC motifs are embedded within the ssdna sequence spaced 28 nt apart. Single deaminations of the 5 C and 3 C are detected as the appearance of labeled 67- and 48-nt fragments, respectively; double deamination of both C residues on the same molecule results in a 30-nt labeled fragment (5 C&3 C). B, deamination of a 118-nt F-labeled ssdna substrate by native and mutant Apo3G. Two 5 CCC motifs are embedded within the ssdna sequence spaced 61 nt apart. Single deaminations of the 5 C and 3 C are detected as the appearance of labeled 100- and 81-nt fragments, respectively; double deamination of both C residues on the same molecule results in a 63-nt labeled fragment (5 C &3 C). C, deamination of the substrate illustrated for B, but with a 20-nt complementary oligonucleotide annealed between the two 5 CCC motifs. Where applicable, the measurements of processivity (processivity factor), polarity (5 C/3 C ratio), and processive efficiency (5 C&3 C/3 C) are shown below the gel. Values are an average from three independent experiments and have an S.E. less than 1. see 5 C/3 C ratio) and deaminates the two C residues processively (Fig. 1A, processivity factor 6). The processivity factor indicates that native Apo3G is 6-fold more likely to catalyze a correlated deamination of the two 5 CCC motifs rather than deaminate each motif in a separate encounter with the ssdna (uncorrelated) (24). The F/W and H186R mutants have similar processivity factors to the native Apo3G (Fig. 1A, compare processivity factors) but demonstrate an 3-fold increase in the deamination polarity toward the 5 -ssdna end (Fig. 1A, compare 5 C/3 C ratios). With these closely spaced CCC motifs, the processivity for the mutants appears to be comparable with the native enzyme. Using a 118-nt substrate with two 5 CCC deamination motifs spaced further apart (61 nt), we tested if the polar and processive properties of the F/W and H186R mutants were retained. Native Apo3G prefers to deaminate the 5 -ssdna end proximal CCC by a factor of 3 (Fig. 1B, 5 C/3 C ratio) with a processivity factor of 8 (Fig. 1B, processivity factor). Similar to the deamination polarity on the shorter ssdna substrate (Fig. 1A), the F/W mutant demonstrates a stronger preference than native Apo3G for C residues at the 5 -ssdna end and is processive (Fig. 1B). The H186R mutant retains a strong preference for deamination of the 5 CCC motif (Fig. 1B, 5 /3 ratio of 13) and exhibits a processivity factor that is similar to native Apo3G (Fig. 1B, processivity factor of 8 for native and H186R). However, when comparing the processivity factor between H186R for CCC motifs 28 and 61 nt apart, there is a 2-fold increase with greater separation of the C residues (Fig. 1, A and B, compare H186R processivity factors). To further test the mechanisms of how the Apo3G mutants scan ssdna, we used a substrate with a dsdna region located between the two 5 CCC motifs (Fig. 1C). This type of dsdna acts as an obstacle to Apo3G because the enzyme cannot bind well to dsdna and is predicted to result in a loss of the sliding component of ssdna scanning (24, 26). Native Apo3G is still able to processively deaminate two C residues with a dsdna region in-between, but with a 2-fold decrease in the processivity factor (Fig. 1, B and C, compare processivity factors of 8 and 4), as characterized previously (26). This suggests that the sliding component of native Apo3G has been blocked by the assay conditions and only the jumping component of the native Apo3G scanning mechanism can result in a processive deamination (24, 26). There is no preference for either the 5 - or3 proximal CCC motif because the dsdna region creates about equal lengths of ssdna regions on the 3 -side of the CCC motifs (Fig. 1C, sketch, 33 or 36 nt), and it is the availability of ssdna in this region that contributes to the deamination polarity of Apo3G (24, 26). For the F/W mutant, there is almost a complete loss of processivity when the enzyme is confronted with a dsdna block as indicated by the processivity factor of 1.5 and near absence of a double deamination band (Fig. 1C, F/W mutant 5 C&3 C band). A nonprocessive enzyme would have a processivity factor of 1 (24). This suggests that there is a deficiency in the ability of the F/W mutant to successfully jump, and the enzyme uses a predominantly sliding mechanism. In contrast, the H186R mutant retains the same processivity factor regardless of whether a dsdna block is present (Fig. 1, B and C, H186R, processivity factors are 8), which suggests that this mutant uses jumping more frequently than native and F/W mutant Apo3G. We can estimate the relative distribution of jumping and sliding events that result in a deamination by calculating the JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 NUMBER 13 APRIL 1, 2011

5 TABLE 1 Apparent dissociation constant of native and mutant Apo3G for ssdna and RNA Apparent dissociation constant (K d ), nm Apo3G ssdna RNA Native F/W mutant H186R correlated deamination efficiency. This is the efficiency with which Apo3G deaminates a 3 C and moves on to deaminate a 5 C or vice versa (31). For the most efficient deamination (3 3 5 ), native Apo3G has a deamination efficiency of 48% on ssdna (Fig. 1B, 5 C &3 C/3 C). On partially dsdna, this decreases to 29%. Therefore, the contribution of jumping is 60% (0.29/0.48) for native Apo3G (Fig. 1, B and C). Using the same calculation, the jumping frequency for the F/W mutant is only 14% (Fig. 1, B and C). In agreement with the F/W mutant exhibiting a predominantly sliding motion on ssdna, the enzyme shows a 4-fold higher binding affinity for ssdna than native Apo3G (Table 1). In contrast, the processive efficiency of H186R is made up of 85% jumping and 15% sliding, which represents an 1.5-fold increase in jumping, at the expense of sliding, from native Apo3G (Fig. 1, B and C, 5 C &3 C/3 C). That the H186R mutant and native Apo3G have a similar binding affinity for ssdna (Table 1) supports the hypothesis that the sliding movements are not decreased with H186R because of a deficiency in ssdna binding but because of a structural change that has altered the balance between jumping and sliding. Apo3G-induced Mutation Spectra in the Protease Gene To examine how jumping and sliding motions affect Apo3G deamination during HIV replication, we used an in vitro model HIV replication system to test the mutagenesis efficiency of native and mutant Apo3G. The in vitro system we developed uses an RNA molecule that is primed for first strand DNA synthesis with a synthetic primer (Fig. 2A). The RNA also has a polypurine tract (PPT) that enables second strand synthesis to occur (data not shown). To the reaction we added NC, RT, and dntps, with or without Apo3G. The RNA produced contains 120 nt of the protease gene from HIV-1 containing the coding region for the active site and flap important for substrate recognition (60, 61). This region in the folded protein is a target for many protease inhibitors (62). Fused to the protease gene is the lacz reporter sequence that is used to differentiate mutated and nonmutated DNA after ligation of the DNA into a plasmid and transformation of the DNA into E. coli (Fig. 2A). The lacz region allows screening for mutated clones (white colonies) among the nonmutated clones (blue colonies). The addition of Apo3G results in an 16-fold increase in the population mutation frequency (frequency of white colonies) than with RT alone (Table 2, 0.94 versus 0.06). Sequences were analyzed in the HIV genome strand orientation where Apo3Gcatalyzed deaminations result in G3A mutations on the coding strand. The mutation pattern of Apo3G in this in vitro system is biased (Fig. 2B) in a manner similar to what has been reported to occur in vivo (20 21). This bias, which can be seen by visual inspection, is due to the 5 cdna region remaining single-stranded the longest and may also be enhanced by the deamination bias of Apo3G (20, 21, 24). The distribution of Apo3G-induced mutations continues as a gradient into the lacz region (supplemental Fig. S1). There are distinct hot spots for Apo3G deamination in the protease region that occur in over 60% of the clones (Fig. 2B). These are 5 AA CC TC (80% of clones, position 2393) and 5 T CC AA (64% of clones, position 2390). However, other 5 CC sites are not deaminated frequently, likely due to the proximity to the PPT that would result in this ssdna region being quickly converted to dsdna, i.e. position that is immediately downstream of the PPT contains a 5 TCC TCC site that is not deaminated in any of the sequenced clones. However, a similar sequence (5 TCC T) at position 2317 demonstrated that Apo3G can deaminate both C residues in this sequence context with a frequency of 4% (Fig. 2B). Apo3G could induce mutagenesis at numerous sites per clone in the protease gene (Fig. 2C). Most of the mutations occurred at 5 GG or 5 GGG sites (Fig. 2D), which represent the preferred deamination site for Apo3G on the first strand cdna (5 CC or 5 CCC). The importance of using the protease gene as a substrate for Apo3G-catalyzed deaminations is that we can assess the level of Apo3G-induced restriction by examining the resulting amino acid changes in the protease-active site (Table 3). Based on a published mutagenesis study of the HIV-1 protease, we are able to infer whether Apo3G-induced mutations cause protease inactivation (Table 3) (63). The mutation spectra agree with genetic changes recovered from patient genomes (64). Notably, in this region of the protease gene, there is a Trp codon (5 TGG). In the cdna, this is a deamination motif for Apo3G (5 CCA) and will always result in a stop codon (5 TAG) being formed if the second C is deaminated by Apo3G (Table 3, amino acid 42). The Apo3G-catalyzed deaminations resulted in 40% of the clones having a stop codon in the protease gene. Other Apo3G-induced mutations that also resulted in a loss of activity occurred more than 30% of the time at the protease amino acids 40, 51, and 52 (Table 3). However, many of the less preferred sites ( 20% mutated clones) resulted in amino acid changes that would preserve protease activity at a comparable level to the wild-type enzyme. In particular, the Asp 3 Asn mutation at amino acid 30 (Table 3) is a known drug resistance mutation for the protease inhibitor nelfinvair (62) and occurred in 16% of the clones. Role of Apo3G Oligomerization in Mutation Induction during Reverse Transcription After establishing the expected mutational spectra in the HIV replication system, we tested the monomeric F/W mutant to determine whether the deficiency in jumping (Fig. 1C) would affect the mutational efficiency of the enzyme in a dynamic system. Based on population mutation frequencies (frequency of white colonies), the F/W monomeric form of Apo3G is 2-fold less able than native Apo3G to induce mutagenesis in the in vitro reverse transcription system (Table 2, 0.94 versus 0.42). In addition, for each clone, the mutational load induced by the F/W mutant in the protease gene was 4-fold less than native Apo3G (compare Fig. 2, B and C, with Fig. 3, A and B, and Table 2). No C targets were mutated more than 20% by the F/W mutant within the sequenced population, and mutations were concentrated nearest the 3 -end of the gene, APRIL 1, 2011 VOLUME 286 NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 11419

6 FIGURE 2. Apo3G-catalyzed deaminations cause extensive mutagenesis of the protease gene in a model HIV replication system. A, sketch of protocol used to detect G3A mutations resulting from Apo3G-catalyzed deaminations occurring during reverse transcription by HIV-1 RT. The DNA substrate formed contains 120 nt of the protease gene (nt ) and 236 nt of the lacz reporter sequence. B, spectrum of G3A mutations caused by Apo3G-catalyzed deaminations in the protease region. C, distribution of mutated clones demonstrating the various numbers of G3A mutations that can be obtained in the protease region per clone. D, DNA sequence data from a subset of four individual clones showing the sequence context of mutations induced by Apo3G in the protease region. Asterisks denote homology. Guanine (G) to adenine (A) mutations are shown in boldface. TABLE 2 Mutation frequencies in a model HIV replication system in the absence and presence of Apo3G Population mutation frequency was measured as the ratio of white colonies to total colonies. Clone mutation frequency was measured per base pair from 368 nt of cdna containing the protease gene region and lacz reporter gene. Only G3A mutations were scored for Apo3G enzymes. All types of mutations were scored for the no Apo3G condition. Reaction condition Population mutation frequency Clone mutation frequency ( 10 2 ) a Native Apo3G F/W mutant 0.42 b 1 c H186R 0.56 a 2 b No Apo3G 0.06 c 0.8 c a Significant difference was designated as p 0.05 versus native Apo3G values. b Significant difference was designated as p 0.01 versus native Apo3G values. c Significant difference was designated as p versus native Apo3G values. corresponding to the 5 -region of cdna that would have remained single-stranded the longest (Fig. 3A). The lacz region was more heavily mutated than the protease gene, but overall the mutation frequency of the F/W mutant was 2-fold less than the native enzyme (compare supplemental Figs. S1 and S2). There were two clones that had over five mutations in the protease gene region, many of which were closely spaced (Fig. 3C, clone 3 (six mutations) and clone 12 (eight mutations)), suggesting that the F/W mutant was still able to act processively by sliding along ssdna, in accordance with Fig. 1. We scored the mutation clustering frequency induced by the F/W mutant and native Apo3G by plotting the number of clones with two or more mutations within a cluster of three to six G residues from eight sites in the protease-lacz construct (Fig. 4). The F/W mutant induced clustered G3A mutations in a manner similar to native Apo3G (Fig. 4, p value 0.5). However, there is a greater standard deviation in the frequency of closely spaced mutations induced by the F/W mutant (Fig. 4), likely due to the inability to cause multiple clusters of mutations per JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 NUMBER 13 APRIL 1, 2011

7 Biochemical Basis of Apo3G Deamination Efficiency clone (Fig. 3B). Regardless of the ability to slide, the F/W mutant-induced mutational load is less than native Apo3G (Table 2 and compare Figs. 3B and 2C), which suggests that jumping is used in conjunction with sliding for native Apo3G. TABLE 3 Amino acid changes to the protease enzyme resulting from Apo3Gcatalyzed deaminations The phenotypic change to the enzyme was determined from mutagenesis studies on the protease enzyme in the literature (63). The term Active refers to the enzyme having wild-type levels of protease activity as defined by Loeb et al. (63). Because the F/W mutant binds the protease RNA with the same affinity as native Apo3G (Table 1), it is unlikely that the RNA present in the model HIV replication assay could trap the F/W mutant or inhibit its activity. In a separate deamination experiment with synthetic ssdna, we found that the substrate usage and processivity of the F/W mutant are not affected by the presence of equimolar competitor RNA trap (data not shown). Rather, these data (Figs. 3 and 4) are consistent with Fig. 1, B and C, and suggest that the use of sliding alone as a DNA scanning mechanism is detrimental to the mutational efficiency of Apo3G. The F/W mutant still retains a preference for deamination of 5 CCC or 5 CC motifs, but the hot spots of the mutant differ from that of native Apo3G (Table 4 and compare Figs. 2B and 3A). The change in the deamination hot spots alters the frequency of amino acid changes in the protease region (Table 3). The most highly mutated site (20% of clones) due to F/W mutant deamination is at amino acid 42 (Trp 3 Stop). Amino acid 52, which is the most highly mutated by native Apo3Gcatalyzed deaminations (80% of clones), is only mutated in 8% of the clones acted on by the F/W mutant (Table 3). The F/W mutant did not induce mutagenesis at amino acid 30 (Table 3), a drug resistance mutation for nelfinvair (62). Clinical H186R Apo3G Mutant We investigated how the decrease in DNA scanning by sliding (Fig. 1C) would influence the H186R-induced mutations during HIV replication. The H186R profile of mutation frequency and distribution differed from native Apo3G (Table 4 and compare Figs. 2B and 5A). The H186R mutant had a population mutation frequency (frequency of white colonies) of 0.56, which is 2-fold less than FIGURE 3. Apo3G monomeric F/W mutant induces a low frequency of mutagenesis in the HIV-1 protease gene. A, spectrum of G3 A mutations caused by F/W mutant-catalyzed deaminations in the protease region. B, distribution of mutated clones demonstrating that the F/W mutant induces a low number of G3 A mutations in the protease region per clone. C, DNA sequence data from a subset of three individual clones showing the sequence context of mutations in a sparse clone (clone 23) and two dense clones (clones 3 and 12) induced by the F/W mutant in the protease region. Asterisks denote homology. Guanine (G) to adenine (A) mutations are shown in boldface. APRIL 1, 2011 VOLUME 286 NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 11421

8 FIGURE 4. Frequency of clustered mutations induced by native and mutant Apo3G. In the 368-nt cdna produced by reverse transcription of the protease gene and lacz reporter gene, there are eight sites with at least three (and up to six) C residues. Within these sites, the frequency of clustered G3A mutations that would have resulted from Apo3G deamination was scored. Horizontal bars represent the average mutation cluster frequency. The data demonstrate that the native Apo3G and F/W mutant induce clustered mutations with a similar frequency (p value 0.528). However, the clustered mutations induced by the H186R mutant was significantly less than native Apo3G (p value 0.003). TABLE 4 Distribution of mutations in the protease gene Frequency of mutation Site (nt) Native F/W mutant H186R a 0.28 b b b 0.20 a b 0.04 b b 0 a c a 0.20 a b 0.04 b a 0.32 a a Significant difference was designated as p versus native Apo3G values. b Significant difference was designated as p 0.01 versus native Apo3G values. c Significant difference was designated as p 0.05 versus native Apo3G values. native Apo3G (Table 2). Most frequently, H186R-catalyzed deaminations induced only 1 2 mutations in the protease gene (Fig. 5B), which results in a 2-fold decrease in the clone mutation frequency from native Apo3G (Table 2). The single sites were deaminated at random and clones with multiple mutations did not show clusters of deaminations as did native Apo3G suggesting that the enzyme is not scanning the DNA by sliding (compare Figs. 5C and 2D). This resulted in a significant decrease in clustered deaminations for H186R compared with native Apo3G (Fig. 4, p value 0.003). More H186R-induced mutations were recovered from the lacz region, but the overall number of mutations per clone was 2-fold less than native Apo3G (compare supplemental Figs. S1 and S3). These differences in the mutational spectra (Table 4) result in different codon changes in the protease region (Table 3). Many of the sites mutated extensively ( 40%) from native Apo3G are mutated about equally ( 20%) in the presence of H186R (Table 3). All together, these data underline the negative effects of the altered ssdna scanning properties of the H186R mutant. Although both the H186R and monomeric F/W mutant were deficient in the mutagenesis efficiency when compared with native Apo3G (compare Figs. 2B,3A, and 5A), for H186R, this is not due to a change in the oligomerization state (Fig. 6). The Rayleigh light scattering chromatograms generated from multiangle light scattering data show that the protein distributions of the monomer and dimer forms are similar for native Apo3G and H186R (Fig. 6, A and B). We also used AFM to demonstrate that H186R can oligomerize on ssdna substrates in a manner similar to native Apo3G (Fig. 6, C F). AFM can be used to determine the volume of proteins, which exhibits a linear relationship with molecular weight (53). The Apo3G native and H186R compositions shift from a distribution of monomers and dimers to a broad distribution of oligomers in the presence of ssdna (Fig. 6, C F). This is in contrast to the F/W mutant, which does not oligomerize in solution or when bound to DNA (25). A prediction from the data for H186R is that the mutant is less efficient at deaminating closely spaced residues because this requires a sliding mechanism. As the distance between C residues decreases, the ability for H186R to act processively should decrease. On a ssdna substrate with two 5 CCC residues spaced 13 nt apart, which is 2-fold less distance than the DNA shown in Fig. 1A (processivity factor 4), the processivity of H186R decreases 2-fold (Fig. 7A, processivity factor 2), whereas the WT processivity remains the same (Fig. 7A, processivity factor 6). To ensure the RNA present in the HIV replication assay did not influence H186R processivity, we added an equimolar concentration of RNA trap to a deamination reaction with ssdna containing two 5 CCC motifs spaced 28 nt apart (Fig. 7B). The competitive RNA trap does not decrease the processivity or substrate usage of H186R or native Apo3G (Fig. 7B) even though H186R has an 8-fold higher binding affinity for RNA than DNA (Table 1). This suggests that the jumping motion of H186R is the same as native Apo3G and that the enzyme maintains a close association with the DNA molecule and does not diffuse into the bulk solution (31). As a result, the changes in the mutation spectrum of H186R appear to be due to an intrinsic decrease in sliding from the enzyme as it is scanning DNA (Fig. 1C). DISCUSSION There has been a lack of understanding of the key mechanistic properties of Apo3G DNA scanning that allows for efficient deamination during HIV replication. To answer this question, we analyzed the Apo3G DNA scanning mechanisms using synthetic DNA substrates and an in vitro model HIV replication system. We demonstrated that the monomeric Apo3G F/W mutant cannot effectively deaminate HIV cdna due to a deficiency in jumping (Figs. 1C and 3). These are the first data to implicate a functionality of oligomers in the mutagenesis process. We found the clinical Apo3G mutant H186R induced less mutagenesis of HIV cdna due to decreased scanning by sliding (Figs. 1C, 4, and 5). These are the first data to biochemically characterize this clinical mutant and suggest a mechanism for the clinical phenotype (41, 42). Because H186R has the same oligomeric profile as native Apo3G (Fig. 6), the data suggest that oligomerization is necessary but not sufficient to restore the native DNA scanning mechanism. The F/W mutant and H186R induce 4- and 2-fold less mutagenesis per clone than native Apo3G (Table 2), respectively, which results in fewer JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 NUMBER 13 APRIL 1, 2011

9 FIGURE 5. Mutagenesis of the HIV-1 protease gene induced by the Apo3G clinical mutant H186R. A, spectrum of G3A mutations caused by H186Rcatalyzed deaminations in the protease region. B, distribution of mutated clones demonstrating that the H186R mutant induces a low number of G3A mutations in the protease region per clone. C, DNA sequence data from a subset of three individual clones showing the sequence context of mutations induced by the H186R mutant in the protease region. Asterisks denote homology. Guanine (G) to adenine (A) mutations are shown in boldface. codon changes in the protease gene (Table 3). Overall, the data indicate that native Apo3G requires both jumping and sliding modes of DNA scanning (Figs. 1 and 2), which are mediated by the N terminus, for efficient deamination and avoidance of sublethal mutagenesis of HIV. Comparing Mutagenesis of the HIV-1 Protease-active Site by Native and Mutant Apo3G We identified 20 different mutations that can be introduced into HIV-1 protease (amino acids 25 52) by Apo3G-catalyzed deaminations (Table 3). Of these 20 mutations, 8 result in a catalytically active protease and 12 inactivate the protease, based on mutagenesis studies of HIV-1 protease (63). Key to this observation is that not all these sites are deaminated equally. Specific sites are more highly mutated due to spatial location or the presence of the preferred sequence context for Apo3G deamination, 5 CC or 5 CCC (20). The most highly preferred sites for deamination at protease codon positions 52, 51, and 42 would result in a loss of protease activity (Table 3), suggesting that if Apo3G has access to this region of the protease gene in vivo, the incurred deaminations would result in viral inactivation. Recently, it has been shown that a low level of mutagenesis (sublethal) may assist HIV-1 to evolve and evade host restriction strategies (36, 38). To consider if Apo3G can contribute to sublethal mutagenesis, we examined the clones that had only one mutation in the protease sequence. From the data in Fig. 2, which tested Apo3G at a concentration estimated to be found in virions (47), there were only three clones with such a low level of mutagenesis, all containing inactivating mutations in codon 52 or 51 (Table 3). To obtain more single mutation clones, we conducted the same experiment, but with 50% less Apo3G added to the reaction. From the 25 clones sequenced, we obtained 8 with a single mutation in the protease gene. From these, 7 of the 8 of the mutations would result in protease inactivation and were randomly distributed between 4 mutational hot spots (codons 52, 51, 42, and 40) (supplemental Fig. S4). Notably, the one clone that did not inactivate HIV-1 protease was located at codon 30, an Asp 3 Asn mutation that can result in resistance to the protease inhibitor nelfinvair (62). As a result, these data cannot exclude that Apo3G contributes to sublethal mutagenesis that may give HIV-1 an evolutionary advantage. Apo3G has also been found to induce resistance to 3TC by inducing a Met 3 Ile mutation in RT (38). However, in the majority of clones, Apo3G was able to introduce multiple inactivating mutations to the protease (Table 3 and Fig. 2C). The F/W mutant and H186R mutant induced less mutagenesis in the protease region than native Apo3G (compare Figs. 2B, 3A, and 5A and Tables 2 and 4). Although in the protease region the F/W mutant and H186R mutant were able to induce mutations that would inactivate the protease 75% of the time (Table 3), considering the decreased number of mutations in the whole HIV-1 genome, we conclude these mutant forms with altered DNA scanning properties will be less likely to cause viral inactivation simply due the decrease in mutations induced. In agreement with this, Bulliard et al. (28) found that the F126L or W127A mutants were 4- or 7-fold less effective at restricting HIV-1 replication than native Apo3G, even after the mutant deficiencies for packaging into HIV virions were corrected through a temporary HIV-Vpr fusion protein. Although the H186R mutant was found, in a cell-based assay, to inhibit HIV-1 infectivity at a level comparable with native Apo3G, the amount of H186R expressed in the transient cellbased expression system was not quantified (41). As a result, the level of H186R in these experiments could have been high enough to overcome the scanning deficiencies, but in our APRIL 1, 2011 VOLUME 286 NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 11423

10 FIGURE 6. Oligomerization state of native and H186R Apo3G in the absence and presence of ssdna. A and B, native (A) and H186R (B) Apo3G were resolved by size exclusion chromatography in running buffer with 200 mm Na 2 SO 4 and 50 mm HEPES, ph 6.7. The Rayleigh light scattering chromatograms show the protein distributions plotted against elution time and demonstrate mutant H186R can oligomerize in a manner similar to native Apo3G. Monomer (46 kda) and dimer (92 kda) peaks are denoted with arrows. C F, AFM can be used to determine the volume of proteins, which exhibits a linear relationship with molecular weight (53). The predicted peaks for a monomer (42 nm 3 ), dimer (97 nm 3 ), and tetramer (208 nm 3 ) are denoted with a bracket. The oligomeric state of native Apo3G (C) alone and in the presence of ssdna (D) demonstrate that native Apo3G composition shifts from a distribution of mostly monomers and dimers (C) to a broad distribution of oligomers in the presence of ssdna (D). The clinical mutant H186R imaged by AFM in the absence (E) and presence (F)of ssdna demonstrated a shift to higher oligomerization states upon the addition of ssdna, similar to native Apo3G. Volume distributions are plotted against percent of total proteins. The total proteins counted were as follows: 1777 (C), 1351 (D), 732 (E), and 1173 (F). Representative AFM images of native and H186R are shown for each condition. Images are nm with a height scale of 5 nm. experiments a level of H186R was used to mimic concentrations found in an HIV virion in vivo (Fig. 5). Because it has been demonstrated that the number of mutations induced by Apo3G correlates with HIV-1 inactivation (65), it is likely that the decreased ability of H186R to induce mutagenesis of HIV DNA would result in a decrease in its effectiveness in vivo. This hypothesis is consistent with the clinical phenotype of high viral loads and decreased CD4 T-cell counts in HIV-1-infected patients (41, 42), but we cannot exclude that other factors may be involved. Structure-based Model for Apo3G DNA Scanning The mutated residues of the F/W mutant (F126A/W127A) are located on loop 7 in the CD1 (supplemental Fig. S5), which mediates dimerization of Apo3G (25). The residues Phe-126 and Trp-127 may also interact directly with DNA and stabilize the DNA-protein interaction (25, 28). The data from the F/W mutant, which demonstrate that mutations in Phe-126 and Trp-127 cause a loss of jumping, suggest that an intact loop 7 is needed for efficient scanning and deamination of HIV cdna (Fig. 3 and Table 2), probably because the enzyme encounters RNA/DNA hybrid regions on the cdna from incomplete RNA degradation. The equivalent loop in the Apo3G CD2 domain (loop 7 2 ) has been shown to contain the determinants for deamination specificity and is thought to mediate an interaction with ssdna (66 69). Because the CD1 domain has a role in determining the processivity and binding affinity of Apo3G for ssdna (25), we suggest that loop 7 in the CD1 is a key structure that mediates the processive jumping mechanism of Apo3G. His-186 is predicted to be located on helix 6 (supplemental Fig. S5). In the CD2 domain, the equivalent helix (helix 6 2 ) was JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 NUMBER 13 APRIL 1, 2011

11 enable Apo3G to undergo a three-dimensional search along DNA substrates for deamination targets, which is a more efficient scanning method than using only one-dimensional sliding (24, 31). The sliding and jumping events of Apo3G are most likely to occur at random; however, for the native Apo3G these events usually result in a successful scan of DNA that leads to a deamination (Fig. 2B). For the mutants, the scanning events appear to be highly unsuccessful in resulting in a deamination during reverse transcription (Tables 2 and 4). The data demonstrate that the distribution between sliding and jumping of Apo3G molecules has evolved to an optimal level in native Apo3G for deamination during HIV-1 replication to provide concentrated regions of mutagenesis (sliding) and to prevent frequent dissociation when RNA/DNA hybrid regions are encountered (jumping). The structural basis for jumping and sliding appears to be mediated by loop 7 and helix 6 in CD1, respectively. This suggests that the balance between sliding and jumping for the oligomer of Apo3G is important to avoid sublethal mutagenesis of the HIV-1 genome. FIGURE 7. Apo3G native and H186R processivity on ssdna with closely spaced cytosines and in the presence of a competitive RNA trap. A, deamination of a 70-nt fluorescein (F)-labeled ssdna substrate by native and H186R Apo3G. Two 5 CCC motifs are embedded within the ssdna sequence spaced 13 nt apart. Single deaminations of the 5 C and 3 C are detected as the appearance of labeled 52- and 33-nt fragments, respectively; double deamination of both C residues on the same molecule results in a 15-nt labeled fragment (5 C &3 C). B, deamination of an 85-nt F-labeled ssdna substrate by native and H186R Apo3G. Two 5 CCC motifs are embedded within the ssdna sequence spaced 28 nt apart. Single deaminations of the 5 C and 3 C are detected as the appearance of labeled 67- and 48-nt fragments, respectively; double deamination of both C residues on the same molecule results in a 30-nt labeled fragment (5 C &3 C). Deamination was carried out in the absence or presence of an equimolar amount of unlabeled competitor RNA (120 nt of HIV-1 protease gene). Where applicable, the measurement of processivity (processivity factor) and substrate usage (%) is shown below the gel. Values are an average from three independent experiments and have an S.E. of less than 1. found to influence DNA binding and activity of Apo3G (66). It has been suggested that helix 6 2 is needed to interact with the negatively charged ssdna backbone through residues Arg-374 and Arg-376 (66). Because His-186 is located in the center of helix 6 (supplemental Fig. S5), similar to Arg-374 and Arg-376 on helix 6 2, we propose that His-186 interacts with the ssdna substrate and is important for mediating DNA scanning. As a result, mutation of this His to Arg could change the interaction with DNA at this site from one that is mediated by base stacking (His) to one that is mediated by the phosphate backbone (Arg). A mutated helix 6 creates an Apo3G with a scanning mechanism that uses jumping more than the native enzyme (Fig. 1C). That the H186R mutant was better able to jump than native Apo3G did not appear to offset the loss of scanning by sliding during reverse transcription (Tables 2 and 4). The ability to transverse the DNA/RNA hybrid regions present throughout the protease gene during reverse transcription was not effective for inducing mutagenesis unless local scanning was involved (Table 2 and Fig. 4). The processive action of native Apo3G appears to be due to a combination of sliding and jumping motions, which together Acknowledgments We thank Dr. Brian Bandy for the use of the fluorometer, Jason Maley at the Saskatchewan Structural Sciences Centre for assistance with AFM, and Dr. Kerri Kobryn for critical review of the manuscript. The SEC-LX/UV/RI instrumentation was supported by National Institutes of Health Award ISI0RR REFERENCES 1. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002) Nature 418, Refsland, E. W., Stenglein, M. D., Shindo, K., Albin, J. S., Brown, W. L., and Harris, R. S. (2010) Nucleic Acids Res. 38, Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., and Malim, M. H. (2003) Cell 113, Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003) Nature 424, Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., and Gao, L. (2003) Nature 424, Conticello, S. G., Harris, R. S., and Neuberger, M. S. (2003) Curr. Biol. 13, Marin, M., Rose, K. M., Kozak, S. L., and Kabat, D. (2003) Nat. Med. 9, Sheehy, A. M., Gaddis, N. C., and Malim, M. H. (2003) Nat. Med. 9, Stopak, K., de Noronha, C., Yonemoto, W., and Greene, W. C. (2003) Mol. Cell 12, Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X. F. (2003) Science 302, Alce, T. M., and Popik, W. (2004) J. Biol. Chem. 279, Bach, D., Peddi, S., Mangeat, B., Lakkaraju, A., Strub, K., and Trono, D. (2008) Retrovirology 5, Bogerd, H. P., and Cullen, B. R. (2008) RNA 14, Burnett, A., and Spearman, P. (2007) J. Virol. 81, Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., and Kleiman, L. (2004) J. Biol. Chem. 279, Douaisi, M., Dussart, S., Courcoul, M., Bessou, G., Vigne, R., and Decroly, E. (2004) Biochem. Biophys. Res. Commun. 321, Khan, M. A., Goila-Gaur, R., Opi, S., Miyagi, E., Takeuchi, H., Kao, S., and Strebel, K. (2007) Retrovirology 4, Strebel, K., and Khan, M. A. (2008) Retrovirology 5, Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W. S., and Pathak, V. K. (2004) J. Biol. Chem. 279, APRIL 1, 2011 VOLUME 286 NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 11425

The APOBEC3G Deamination Independent. Mode of HIV Inhibition

The APOBEC3G Deamination Independent. Mode of HIV Inhibition The APOBEC3G Deamination Independent Mode of HIV Inhibition A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the Requirements for the Degree of Master of Science

More information

JANUARY 27, 2006 VOLUME 281 NUMBER 4 JOURNAL OF BIOLOGICAL CHEMISTRY 1943

JANUARY 27, 2006 VOLUME 281 NUMBER 4 JOURNAL OF BIOLOGICAL CHEMISTRY 1943 THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 281, NO. 4, pp. 1943 1955, January 27, 2006 2006 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A. Sequence, Distance,

More information

Structural Characterization of Prion-like Conformational Changes of the Neuronal Isoform of Aplysia CPEB

Structural Characterization of Prion-like Conformational Changes of the Neuronal Isoform of Aplysia CPEB Structural Characterization of Prion-like Conformational Changes of the Neuronal Isoform of Aplysia CPEB Bindu L. Raveendra, 1,5 Ansgar B. Siemer, 2,6 Sathyanarayanan V. Puthanveettil, 1,3,7 Wayne A. Hendrickson,

More information

Nature Methods: doi: /nmeth Supplementary Figure 1

Nature Methods: doi: /nmeth Supplementary Figure 1 Supplementary Figure 1 Subtiligase-catalyzed ligations with ubiquitin thioesters and 10-mer biotinylated peptides. (a) General scheme for ligations between ubiquitin thioesters and 10-mer, biotinylated

More information

reads observed in trnas from the analysis of RNAs carrying a 5 -OH ends isolated from cells induced to express

reads observed in trnas from the analysis of RNAs carrying a 5 -OH ends isolated from cells induced to express Supplementary Figure 1. VapC-mt4 cleaves trna Ala2 in E. coli. Histograms representing the fold change in reads observed in trnas from the analysis of RNAs carrying a 5 -OH ends isolated from cells induced

More information

Received 29 December 1998/Accepted 9 March 1999

Received 29 December 1998/Accepted 9 March 1999 JOURNAL OF VIROLOGY, June 1999, p. 4794 4805 Vol. 73, No. 6 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Molecular Requirements for Human Immunodeficiency

More information

Human Immunodeficiency Virus Type 2 Reverse Transcriptase Activity in Model Systems That Mimic Steps in Reverse Transcription

Human Immunodeficiency Virus Type 2 Reverse Transcriptase Activity in Model Systems That Mimic Steps in Reverse Transcription JOURNAL OF VIROLOGY, July 2003, p. 7623 7634 Vol. 77, No. 13 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.13.7623 7634.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Human Immunodeficiency

More information

Supplementary Figure 1

Supplementary Figure 1 Supplementary Figure 1 Asymmetrical function of 5p and 3p arms of mir-181 and mir-30 families and mir-142 and mir-154. (a) Control experiments using mirna sensor vector and empty pri-mirna overexpression

More information

Phosphate buffered saline (PBS) for washing the cells TE buffer (nuclease-free) ph 7.5 for use with the PrimePCR Reverse Transcription Control Assay

Phosphate buffered saline (PBS) for washing the cells TE buffer (nuclease-free) ph 7.5 for use with the PrimePCR Reverse Transcription Control Assay Catalog # Description 172-5080 SingleShot Cell Lysis Kit, 100 x 50 µl reactions 172-5081 SingleShot Cell Lysis Kit, 500 x 50 µl reactions For research purposes only. Introduction The SingleShot Cell Lysis

More information

Template Dimerization Promotes an Acceptor Invasion-Induced Transfer Mechanism during Human Immunodeficiency Virus Type 1 Minus-Strand Synthesis

Template Dimerization Promotes an Acceptor Invasion-Induced Transfer Mechanism during Human Immunodeficiency Virus Type 1 Minus-Strand Synthesis JOURNAL OF VIROLOGY, Apr. 2003, p. 4710 4721 Vol. 77, No. 8 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.8.4710 4721.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Template Dimerization

More information

Human Immunodeficiency Virus

Human Immunodeficiency Virus Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease

More information

Department of Microbiology, School of Medicine, Box , University of Washington, Seattle, WA 98195, USA

Department of Microbiology, School of Medicine, Box , University of Washington, Seattle, WA 98195, USA Virology 366 (2007) 361 376 www.elsevier.com/locate/yviro Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks

More information

Inhibition of trna 3 Lys -Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication

Inhibition of trna 3 Lys -Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication JOURNAL OF VIROLOGY, Dec. 2006, p. 11710 11722 Vol. 80, No. 23 0022-538X/06/$08.00 0 doi:10.1128/jvi.01038-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Inhibition of trna

More information

Introduction retroposon

Introduction retroposon 17.1 - Introduction A retrovirus is an RNA virus able to convert its sequence into DNA by reverse transcription A retroposon (retrotransposon) is a transposon that mobilizes via an RNA form; the DNA element

More information

Reverse transcription and integration

Reverse transcription and integration Reverse transcription and integration Lecture 9 Biology 3310/4310 Virology Spring 2018 One can t believe impossible things, said Alice. I dare say you haven t had much practice, said the Queen. Why, sometimes

More information

L I F E S C I E N C E S

L I F E S C I E N C E S 1a L I F E S C I E N C E S 5 -UUA AUA UUC GAA AGC UGC AUC GAA AAC UGU GAA UCA-3 5 -TTA ATA TTC GAA AGC TGC ATC GAA AAC TGT GAA TCA-3 3 -AAT TAT AAG CTT TCG ACG TAG CTT TTG ACA CTT AGT-5 OCTOBER 31, 2006

More information

7.012 Quiz 3 Answers

7.012 Quiz 3 Answers MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84

More information

Molecular Mechanisms by Which Human Immunodeficiency Virus Type 1 Integrase Stimulates the Early Steps of Reverse Transcription

Molecular Mechanisms by Which Human Immunodeficiency Virus Type 1 Integrase Stimulates the Early Steps of Reverse Transcription JOURNAL OF VIROLOGY, Sept. 2007, p. 10037 10046 Vol. 81, No. 18 0022-538X/07/$08.00 0 doi:10.1128/jvi.00519-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Molecular Mechanisms

More information

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere q HIV-1/2 Detect WHO reference number: PQDx 0226-032-00 Alere q HIV-1/2 Detect with product codes 270110050, 270110010 and 270300001,

More information

Materials and Methods , The two-hybrid principle.

Materials and Methods , The two-hybrid principle. The enzymatic activity of an unknown protein which cleaves the phosphodiester bond between the tyrosine residue of a viral protein and the 5 terminus of the picornavirus RNA Introduction Every day there

More information

1. Identify and characterize interesting phenomena! 2. Characterization should stimulate some questions/models! 3. Combine biochemistry and genetics

1. Identify and characterize interesting phenomena! 2. Characterization should stimulate some questions/models! 3. Combine biochemistry and genetics 1. Identify and characterize interesting phenomena! 2. Characterization should stimulate some questions/models! 3. Combine biochemistry and genetics to gain mechanistic insight! 4. Return to step 2, as

More information

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx 0115-041-00 Abstract The VERSANT HIV-1 RNA 1.0 Assay (kpcr) with product codes 10375763,

More information

CHAPTER 4 RESULTS. showed that all three replicates had similar growth trends (Figure 4.1) (p<0.05; p=0.0000)

CHAPTER 4 RESULTS. showed that all three replicates had similar growth trends (Figure 4.1) (p<0.05; p=0.0000) CHAPTER 4 RESULTS 4.1 Growth Characterization of C. vulgaris 4.1.1 Optical Density Growth study of Chlorella vulgaris based on optical density at 620 nm (OD 620 ) showed that all three replicates had similar

More information

Characterization of the DNA-mediated Oxidation of Dps, a Bacterial Ferritin

Characterization of the DNA-mediated Oxidation of Dps, a Bacterial Ferritin SUPPORTING INFORMATION Characterization of the DNA-mediated Oxidation of Dps, a Bacterial Ferritin Anna R. Arnold, Andy Zhou, and Jacqueline K. Barton Division of Chemistry and Chemical Engineering, California

More information

SUPPLEMENTAL INFORMATION

SUPPLEMENTAL INFORMATION SUPPLEMENTAL INFORMATION EXPERIMENTAL PROCEDURES Tryptic digestion protection experiments - PCSK9 with Ab-3D5 (1:1 molar ratio) in 50 mm Tris, ph 8.0, 150 mm NaCl was incubated overnight at 4 o C. The

More information

RECAP (1)! In eukaryotes, large primary transcripts are processed to smaller, mature mrnas.! What was first evidence for this precursorproduct

RECAP (1)! In eukaryotes, large primary transcripts are processed to smaller, mature mrnas.! What was first evidence for this precursorproduct RECAP (1) In eukaryotes, large primary transcripts are processed to smaller, mature mrnas. What was first evidence for this precursorproduct relationship? DNA Observation: Nuclear RNA pool consists of

More information

7.014 Problem Set 7 Solutions

7.014 Problem Set 7 Solutions MIT Department of Biology 7.014 Introductory Biology, Spring 2005 7.014 Problem Set 7 Solutions Question 1 Part A Antigen binding site Antigen binding site Variable region Light chain Light chain Variable

More information

Life Sciences 1A Midterm Exam 2. November 13, 2006

Life Sciences 1A Midterm Exam 2. November 13, 2006 Name: TF: Section Time Life Sciences 1A Midterm Exam 2 November 13, 2006 Please write legibly in the space provided below each question. You may not use calculators on this exam. We prefer that you use

More information

Overview of the Expressway Cell-Free Expression Systems. Expressway Mini Cell-Free Expression System

Overview of the Expressway Cell-Free Expression Systems. Expressway Mini Cell-Free Expression System Overview of the Expressway Cell-Free Expression Systems The Expressway Cell-Free Expression Systems use an efficient coupled transcription and translation reaction to produce up to milligram quantities

More information

Section 6. Junaid Malek, M.D.

Section 6. Junaid Malek, M.D. Section 6 Junaid Malek, M.D. The Golgi and gp160 gp160 transported from ER to the Golgi in coated vesicles These coated vesicles fuse to the cis portion of the Golgi and deposit their cargo in the cisternae

More information

Peptide hydrolysis uncatalyzed half-life = ~450 years HIV protease-catalyzed half-life = ~3 seconds

Peptide hydrolysis uncatalyzed half-life = ~450 years HIV protease-catalyzed half-life = ~3 seconds Uncatalyzed half-life Peptide hydrolysis uncatalyzed half-life = ~450 years IV protease-catalyzed half-life = ~3 seconds Life Sciences 1a Lecture Slides Set 9 Fall 2006-2007 Prof. David R. Liu In the absence

More information

This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is worth 2 points.

This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is worth 2 points. MBB 407/511 Molecular Biology and Biochemistry First Examination - October 1, 2002 Name Social Security Number This exam consists of two parts. Part I is multiple choice. Each of these 25 questions is

More information

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist Identification of Mutation(s) in the HIV 1 gp41 Subunit Associated with Neutralization Resistance Miah Blomquist What is HIV 1? HIV-1 is an epidemic that affects over 34 million people worldwide. HIV-1

More information

Molecular Biology (BIOL 4320) Exam #2 May 3, 2004

Molecular Biology (BIOL 4320) Exam #2 May 3, 2004 Molecular Biology (BIOL 4320) Exam #2 May 3, 2004 Name SS# This exam is worth a total of 100 points. The number of points each question is worth is shown in parentheses after the question number. Good

More information

A Novel in Vitro Replication System for Dengue Virus

A Novel in Vitro Replication System for Dengue Virus THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 274, No. 47, Issue of November 19, pp. 33714 33722, 1999 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. A Novel in

More information

Practice Problems 8. a) What do we define as a beneficial or advantageous mutation to the virus? Why?

Practice Problems 8. a) What do we define as a beneficial or advantageous mutation to the virus? Why? Life Sciences 1a Practice Problems 8 1. You have two strains of HIV one is a wild type strain of HIV and the second has acquired a mutation in the gene encoding the protease. This mutation has a dual effect

More information

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell October 26, 2006 Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell 1. Secretory pathway a. Formation of coated vesicles b. SNAREs and vesicle targeting 2. Membrane fusion a. SNAREs

More information

Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma

Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma Excerpt from MACS&more Vol 8 1/2004 Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma L. Davis Lupo and Salvatore T. Butera HIV and Retrovirology Branch,

More information

Supplemental Figure S1. Expression of Cirbp mrna in mouse tissues and NIH3T3 cells.

Supplemental Figure S1. Expression of Cirbp mrna in mouse tissues and NIH3T3 cells. SUPPLEMENTAL FIGURE AND TABLE LEGENDS Supplemental Figure S1. Expression of Cirbp mrna in mouse tissues and NIH3T3 cells. A) Cirbp mrna expression levels in various mouse tissues collected around the clock

More information

Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H

Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H Newly Synthesized APOBEC3G Is Incorporated into HIV Virions, Inhibited by HIV RNA, and Subsequently Activated by RNase H Vanessa B. Soros 1, Wes Yonemoto 1, Warner C. Greene 1,2,3* 1 Gladstone Institute

More information

Lecture 2: Virology. I. Background

Lecture 2: Virology. I. Background Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a

More information

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. HEK293T

More information

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za ARV Mode of Action Mode of Action Mode of Action - NRTI Mode of Action - NNRTI Mode of Action - Protease Inhibitors Mode of Action - Integrase inhibitor Mode of Action - Entry Inhibitors Mode of Action

More information

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Margaret S Ebert, Joel R Neilson & Phillip A Sharp Supplementary figures and text: Supplementary Figure 1. Effect of sponges on

More information

EXOSOMES & MICROVESICLES

EXOSOMES & MICROVESICLES The Sample Preparation Experts EXOSOMES & MICROVESICLES The New Standard in Exosome Purification and RNA Isolation Best-in-Class, Pure & Simple Exosome Purification, Fractionation of Exosomal Free & Circulating

More information

AP Biology Summer Assignment Chapter 3 Quiz

AP Biology Summer Assignment Chapter 3 Quiz AP Biology Summer Assignment Chapter 3 Quiz 2016-17 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. All of the following are found in a DNA nucleotide

More information

Ali Alabbadi. Bann. Bann. Dr. Belal

Ali Alabbadi. Bann. Bann. Dr. Belal 31 Ali Alabbadi Bann Bann Dr. Belal Topics to be discussed in this sheet: Particles-to-PFU Single-step and multi-step growth cycles Multiplicity of infection (MOI) Physical measurements of virus particles

More information

Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay

Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against

More information

AIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria

AIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria AIDS - Knowledge and Dogma Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/17 2010, Vienna, Austria Reliability of PCR to detect genetic sequences from HIV Juan Manuel

More information

Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS)

Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS) Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS) and their exosomes (EXO) in resting (REST) and activated

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Choi YL, Soda M, Yamashita Y, et al. EML4-ALK mutations in

More information

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves

More information

HIV INFECTION: An Overview

HIV INFECTION: An Overview HIV INFECTION: An Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ

More information

Supplementary Material

Supplementary Material Supplementary Material Nuclear import of purified HIV-1 Integrase. Integrase remains associated to the RTC throughout the infection process until provirus integration occurs and is therefore one likely

More information

Translation. Host Cell Shutoff 1) Initiation of eukaryotic translation involves many initiation factors

Translation. Host Cell Shutoff 1) Initiation of eukaryotic translation involves many initiation factors Translation Questions? 1) How does poliovirus shutoff eukaryotic translation? 2) If eukaryotic messages are not translated how can poliovirus get its message translated? Host Cell Shutoff 1) Initiation

More information

Interaction of NPR1 with basic leucine zipper protein transcription factors that bind sequences required for salicylic acid induction of the PR-1 gene

Interaction of NPR1 with basic leucine zipper protein transcription factors that bind sequences required for salicylic acid induction of the PR-1 gene Interaction of NPR1 with basic leucine zipper protein transcription factors that bind sequences required for salicylic acid induction of the PR-1 gene YUELIN ZHANG, WEIHUA FAN, MARK KINKEMA, XIN LI, AND

More information

Under the Radar Screen: How Bugs Trick Our Immune Defenses

Under the Radar Screen: How Bugs Trick Our Immune Defenses Under the Radar Screen: How Bugs Trick Our Immune Defenses Session 7: Cytokines Marie-Eve Paquet and Gijsbert Grotenbreg Whitehead Institute for Biomedical Research HHV-8 Discovered in the 1980 s at the

More information

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4

More information

SUPPLEMENTARY INFORMATION. An orthogonal ribosome-trnas pair by the engineering of

SUPPLEMENTARY INFORMATION. An orthogonal ribosome-trnas pair by the engineering of SUPPLEMENTARY INFORMATION An orthogonal ribosome-trnas pair by the engineering of peptidyl transferase center Naohiro Terasaka 1 *, Gosuke Hayashi 1 *, Takayuki Katoh 1, and Hiroaki Suga 1,2 1 Department

More information

Biochemistry 2000 Sample Question Transcription, Translation and Lipids. (1) Give brief definitions or unique descriptions of the following terms:

Biochemistry 2000 Sample Question Transcription, Translation and Lipids. (1) Give brief definitions or unique descriptions of the following terms: (1) Give brief definitions or unique descriptions of the following terms: (a) exon (b) holoenzyme (c) anticodon (d) trans fatty acid (e) poly A tail (f) open complex (g) Fluid Mosaic Model (h) embedded

More information

Construction of a hepatocellular carcinoma cell line that stably expresses stathmin with a Ser25 phosphorylation site mutation

Construction of a hepatocellular carcinoma cell line that stably expresses stathmin with a Ser25 phosphorylation site mutation Construction of a hepatocellular carcinoma cell line that stably expresses stathmin with a Ser25 phosphorylation site mutation J. Du 1, Z.H. Tao 2, J. Li 2, Y.K. Liu 3 and L. Gan 2 1 Department of Chemistry,

More information

Supplementary Figure 1

Supplementary Figure 1 Supplementary Figure 1 Isolation of mt-trnas and RNA-MS analysis of mt-trna Asn from M. nudus (a)m. nudus mt-trnas were isolated by RCC and resolved by 10% denaturing PAGE. The gel was stained with SYBR

More information

Biology Open (2014) 000, 1 10 doi: /bio

Biology Open (2014) 000, 1 10 doi: /bio (2014) 000, 1 10 doi:10.1242/bio.201410041 Supplementary Material Michael Brauchle et al. doi: 10.1242/bio.201410041 Fig. S1. Alignment of GFP, sfgfp, egfp, eyfp, mcherry and mruby2. Sequence-based alignment

More information

Sections 12.3, 13.1, 13.2

Sections 12.3, 13.1, 13.2 Sections 12.3, 13.1, 13.2 Now that the DNA has been copied, it needs to send its genetic message to the ribosomes so proteins can be made Transcription: synthesis (making of) an RNA molecule from a DNA

More information

Supplementary Figure 1 (previous page). EM analysis of full-length GCGR. (a) Exemplary tilt pair images of the GCGR mab23 complex acquired for Random

Supplementary Figure 1 (previous page). EM analysis of full-length GCGR. (a) Exemplary tilt pair images of the GCGR mab23 complex acquired for Random S1 Supplementary Figure 1 (previous page). EM analysis of full-length GCGR. (a) Exemplary tilt pair images of the GCGR mab23 complex acquired for Random Conical Tilt (RCT) reconstruction (left: -50,right:

More information

Self-Priming of Retroviral Minus-Strand Strong-Stop DNAs

Self-Priming of Retroviral Minus-Strand Strong-Stop DNAs Virology 285, 278 290 (2001) doi:10.1006/viro.2001.0970, available online at http://www.idealibrary.com on Self-Priming of Retroviral Minus-Strand Strong-Stop DNAs Marie-Pierre Golinelli and Stephen H.

More information

Proteins? Protein function. Protein folding. Protein folding diseases. Protein interactions. Macromolecular assemblies. The end product of Genes

Proteins? Protein function. Protein folding. Protein folding diseases. Protein interactions. Macromolecular assemblies. The end product of Genes Proteins? Protein function Protein folding Protein folding diseases Protein interactions Macromolecular assemblies The end product of Genes Protein Unfolding DOD Acid Catalysis DOD HDOD + N H N D C N C

More information

MedChem 401~ Retroviridae. Retroviridae

MedChem 401~ Retroviridae. Retroviridae MedChem 401~ Retroviridae Retroviruses plus-sense RNA genome (!8-10 kb) protein capsid lipid envelop envelope glycoproteins reverse transcriptase enzyme integrase enzyme protease enzyme Retroviridae The

More information

Tivadar Orban, Beata Jastrzebska, Sayan Gupta, Benlian Wang, Masaru Miyagi, Mark R. Chance, and Krzysztof Palczewski

Tivadar Orban, Beata Jastrzebska, Sayan Gupta, Benlian Wang, Masaru Miyagi, Mark R. Chance, and Krzysztof Palczewski Structure, Volume Supplemental Information Conformational Dynamics of Activation for the Pentameric Complex of Dimeric G Protein-Coupled Receptor and Heterotrimeric G Protein Tivadar Orban, Beata Jastrzebska,

More information

Viral Genetics. BIT 220 Chapter 16

Viral Genetics. BIT 220 Chapter 16 Viral Genetics BIT 220 Chapter 16 Details of the Virus Classified According to a. DNA or RNA b. Enveloped or Non-Enveloped c. Single-stranded or double-stranded Viruses contain only a few genes Reverse

More information

HIV and drug resistance Simon Collins UK-CAB 1 May 2009

HIV and drug resistance Simon Collins UK-CAB 1 May 2009 HIV and drug resistance Simon Collins UK-CAB 1 May 2009 slides: thanks to Prof Clive Loveday, Intl. Clinical Virology Centre www.icvc.org.uk Tip of the iceberg = HIV result, CD4, VL Introduction: resistance

More information

CDC website:

CDC website: Hepatitis B virus CDC website: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_1.htm Relevance Key Features es of Hepatitis t B Virus 250 million people infected worldwide. In areas of

More information

Supplementary Table 1. Properties of lysates of E. coli strains expressing CcLpxI point mutants

Supplementary Table 1. Properties of lysates of E. coli strains expressing CcLpxI point mutants Supplementary Table 1. Properties of lysates of E. coli strains expressing CcLpxI point mutants Species UDP-2,3- diacylglucosamine hydrolase specific activity (nmol min -1 mg -1 ) Fold vectorcontrol specific

More information

Tel: ; Fax: ;

Tel: ; Fax: ; Tel.: +98 216 696 9291; Fax: +98 216 696 9291; E-mail: mrasadeghi@pasteur.ac.ir Tel: +98 916 113 7679; Fax: +98 613 333 6380; E-mail: abakhshi_e@ajums.ac.ir A Soluble Chromatin-bound MOI 0 1 5 0 1 5 HDAC2

More information

Sequences in the 5 and 3 R Elements of Human Immunodeficiency Virus Type 1 Critical for Efficient Reverse Transcription

Sequences in the 5 and 3 R Elements of Human Immunodeficiency Virus Type 1 Critical for Efficient Reverse Transcription JOURNAL OF VIROLOGY, Sept. 2000, p. 8324 8334 Vol. 74, No. 18 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Sequences in the 5 and 3 R Elements of Human

More information

Luminescent platforms for monitoring changes in the solubility of amylin and huntingtin in living cells

Luminescent platforms for monitoring changes in the solubility of amylin and huntingtin in living cells Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2016 Contents Supporting Information Luminescent platforms for monitoring changes in the

More information

Plasmids Western blot analysis and immunostaining Flow Cytometry Cell surface biotinylation RNA isolation and cdna synthesis

Plasmids Western blot analysis and immunostaining Flow Cytometry Cell surface biotinylation RNA isolation and cdna synthesis Plasmids psuper-retro-s100a10 shrna1 was constructed by cloning the dsdna oligo 5 -GAT CCC CGT GGG CTT CCA GAG CTT CTT TCA AGA GAA GAA GCT CTG GAA GCC CAC TTT TTA-3 and 5 -AGC TTA AAA AGT GGG CTT CCA GAG

More information

A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis

A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis APPLICATION NOTE Cell-Free DNA Isolation Kit A complete next-generation sequencing workfl ow for circulating cell-free DNA isolation and analysis Abstract Circulating cell-free DNA (cfdna) has been shown

More information

Last time we talked about the few steps in viral replication cycle and the un-coating stage:

Last time we talked about the few steps in viral replication cycle and the un-coating stage: Zeina Al-Momani Last time we talked about the few steps in viral replication cycle and the un-coating stage: Un-coating: is a general term for the events which occur after penetration, we talked about

More information

Point total. Page # Exam Total (out of 90) The number next to each intermediate represents the total # of C-C and C-H bonds in that molecule.

Point total. Page # Exam Total (out of 90) The number next to each intermediate represents the total # of C-C and C-H bonds in that molecule. This exam is worth 90 points. Pages 2- have questions. Page 1 is for your reference only. Honor Code Agreement - Signature: Date: (You agree to not accept or provide assistance to anyone else during this

More information

Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell October 26, 2006 1 Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell 1. Secretory pathway a. Formation of coated vesicles b. SNAREs and vesicle targeting 2. Membrane fusion a. SNAREs

More information

Transient Ribosomal Attenuation Coordinates Protein Synthesis and Co-translational Folding

Transient Ribosomal Attenuation Coordinates Protein Synthesis and Co-translational Folding SUPPLEMENTARY INFORMATION: Transient Ribosomal Attenuation Coordinates Protein Synthesis and Co-translational Folding Gong Zhang 1,2, Magdalena Hubalewska 1 & Zoya Ignatova 1,2 1 Department of Cellular

More information

Chemistry 135, First Exam. September 23, Chem 135, Exam 1 SID:

Chemistry 135, First Exam. September 23, Chem 135, Exam 1 SID: Chemistry 135, First Exam September 23, 2015 This exam will be worth 15% of your overall grade. Please read all instructions/questions carefully and provide answers in the space provided. There should

More information

Islamic University Faculty of Medicine

Islamic University Faculty of Medicine Islamic University Faculty of Medicine 2012 2013 2 RNA is a modular structure built from a combination of secondary and tertiary structural motifs. RNA chains fold into unique 3 D structures, which act

More information

Product Manual. Omni-Array Sense Strand mrna Amplification Kit, 2 ng to 100 ng Version Catalog No.: Reactions

Product Manual. Omni-Array Sense Strand mrna Amplification Kit, 2 ng to 100 ng Version Catalog No.: Reactions Genetic Tools and Reagents Universal mrna amplification, sense strand amplification, antisense amplification, cdna synthesis, micro arrays, gene expression, human, mouse, rat, guinea pig, cloning Omni-Array

More information

ABSTRACT. Human immunodeficiency virus reverse transcriptase (HIV-RT) binds more stably in

ABSTRACT. Human immunodeficiency virus reverse transcriptase (HIV-RT) binds more stably in ABSTRACT Title of Document: A COMPARATIVE ANALYSIS OF THE BINDING AFFINITY OF HIV-1 REVERSE TRANSCRIPTASE TO DNA vs. RNA SUBSTRATES Jeffrey T. Olimpo, Jr., Master of Science, 2010 Directed By: Dr. Jeffrey

More information

Chemistry 107 Exam 4 Study Guide

Chemistry 107 Exam 4 Study Guide Chemistry 107 Exam 4 Study Guide Chapter 10 10.1 Recognize that enzyme catalyze reactions by lowering activation energies. Know the definition of a catalyst. Differentiate between absolute, relative and

More information

DNA codes for RNA, which guides protein synthesis.

DNA codes for RNA, which guides protein synthesis. Section 3: DNA codes for RNA, which guides protein synthesis. K What I Know W What I Want to Find Out L What I Learned Vocabulary Review synthesis New RNA messenger RNA ribosomal RNA transfer RNA transcription

More information

numbe r Done by Corrected by Doctor

numbe r Done by Corrected by Doctor numbe r 5 Done by Mustafa Khader Corrected by Mahdi Sharawi Doctor Ashraf Khasawneh Viral Replication Mechanisms: (Protein Synthesis) 1. Monocistronic Method: All human cells practice the monocistronic

More information

Mechanistic differences between HIV 1 and SIV nucleocapsid proteins and cross species HIV 1 genomic RNA recognition

Mechanistic differences between HIV 1 and SIV nucleocapsid proteins and cross species HIV 1 genomic RNA recognition DOI 10.1186/s12977-016-0322-5 Retrovirology RESEARCH Open Access Mechanistic differences between HIV 1 and SIV nucleocapsid proteins and cross species HIV 1 genomic RNA recognition Klara Post 1, Erik D.

More information

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data Breast cancer Inferring Transcriptional Module from Breast Cancer Profile Data Breast Cancer and Targeted Therapy Microarray Profile Data Inferring Transcriptional Module Methods CSC 177 Data Warehousing

More information

CRY2 binding to CIB1N w/ MTHF

CRY2 binding to CIB1N w/ MTHF Supplemental Figures: CRY2 binding to CIB1N w/ MTHF.36 Polarization.34.32.3.28 Blue.26 5 1 15 [Cry2] in nm Figure S1: Addition of MTHF does not significantly change CRY2- CIB1N binding. Direct fluorescence

More information

Chapter 6- An Introduction to Viruses*

Chapter 6- An Introduction to Viruses* Chapter 6- An Introduction to Viruses* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. 6.1 Overview of Viruses

More information

Supplementary Figure 1 Preparation, crystallization and structure determination of EpEX. (a), Purified EpEX and EpEX analyzed on homogenous 12.

Supplementary Figure 1 Preparation, crystallization and structure determination of EpEX. (a), Purified EpEX and EpEX analyzed on homogenous 12. Supplementary Figure 1 Preparation, crystallization and structure determination of EpEX. (a), Purified EpEX and EpEX analyzed on homogenous 12.5 % SDS-PAGE gel under reducing and non-reducing conditions.

More information

answer Marks Guidance 1 (a) 2 max Mark the first answer on each prompt line. ACCEPT ora throughout nucleus / nuclei ; 1 ACCEPT DNA not free

answer Marks Guidance 1 (a) 2 max Mark the first answer on each prompt line. ACCEPT ora throughout nucleus / nuclei ; 1 ACCEPT DNA not free Question answer Marks Guidance 1 (a) max Mark the first answer on each prompt line. ACCEPT ora throughout 1 6 7 nucleus / nuclei ; other named organelle / membrane bound organelles ; linear chromosomes

More information

Received 26 January 1996/Returned for modification 28 February 1996/Accepted 15 March 1996

Received 26 January 1996/Returned for modification 28 February 1996/Accepted 15 March 1996 MOLECULAR AND CELLULAR BIOLOGY, June 1996, p. 3012 3022 Vol. 16, No. 6 0270-7306/96/$04.00 0 Copyright 1996, American Society for Microbiology Base Pairing at the 5 Splice Site with U1 Small Nuclear RNA

More information

3) How many different amino acids are proteogenic in eukaryotic cells? A) 12 B) 20 C) 25 D) 30 E) None of the above

3) How many different amino acids are proteogenic in eukaryotic cells? A) 12 B) 20 C) 25 D) 30 E) None of the above Suggesting questions for Biochemistry 1 and 2 and clinical biochemistry 1) Henderson Hasselbalch Equation shows: A) The relationship between ph and the concentration of an acid and its conjugate base B)

More information

SUPPLEMENTARY INFORMATION. Divergent TLR7/9 signaling and type I interferon production distinguish

SUPPLEMENTARY INFORMATION. Divergent TLR7/9 signaling and type I interferon production distinguish SUPPLEMENTARY INFOATION Divergent TLR7/9 signaling and type I interferon production distinguish pathogenic and non-pathogenic AIDS-virus infections Judith N. Mandl, Ashley P. Barry, Thomas H. Vanderford,

More information

Chemical Mechanism of Enzymes

Chemical Mechanism of Enzymes Chemical Mechanism of Enzymes Enzyme Engineering 5.2 Definition of the mechanism 1. The sequence from substrate(s) to product(s) : Reaction steps 2. The rates at which the complex are interconverted 3.

More information

HIV & AIDS: Overview

HIV & AIDS: Overview HIV & AIDS: Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR VJ TEMPLE 1 What

More information